Ketamine & Axillary Block: Pain Relief & Recovery – Cureus

Ketamine Boosts Pain Relief in Shoulder Surgery, Study Finds

A new study reveals that supplementing axillary plexus blockades with ketamine significantly improves post-operative pain management and reduces opioid consumption following shoulder surgery.The research, published in Cureus, offers a promising avenue for enhancing patient recovery and addressing the ongoing opioid crisis.

Researchers conducted a comparative study involving patients undergoing shoulder arthroscopic surgery. Participants were divided into two groups: one receiving a standard axillary plexus block, and the other receiving the block supplemented with ketamine. The primary outcomes measured were visual analog scale (VAS) pain scores at various time points post-surgery, as well as the total amount of opioid analgesic consumption within the first 24 hours.

Enhanced Pain Control with Ketamine Supplementation

The study demonstrated a statistically meaningful reduction in pain scores in the ketamine group compared to the control group across multiple time intervals. Specifically, patients receiving ketamine reported lower pain levels at 6, 12, and 24 hours after surgery. “The difference in pain scores was quite noticeable, particularly in the initial recovery period,” one researcher stated.

This finding suggests that ketamine’s analgesic properties, when combined with regional anesthesia, provide a synergistic affect, leading to more effective pain control. The mechanism behind this synergy is believed to involve ketamine’s action on NMDA receptors in the central nervous system, modulating pain pathways.

Did you know? – Axillary plexus blockades temporarily numb the shoulder and arm, providing pain relief during and after surgery. They work by blocking nerve signals in the area.

Reduced Opioid Reliance Post-Surgery

Perhaps even more significantly, the ketamine supplemented group exhibited a substantial decrease in opioid consumption. The average amount of morphine equivalent consumed in the first 24 hours was considerably lower in the ketamine group. This reduction is crucial given the growing concerns surrounding opioid addiction and the potential for long-term dependence.

“Minimizing opioid use post-operatively is a major goal in modern surgical practice,” a senior official commented. “This study provides compelling evidence that ketamine supplementation can help achieve that goal without compromising patient comfort.”

Implications for Axillary Plexus Blockade Protocols

The findings have vital implications for clinical practice. Axillary plexus blockades are commonly used for shoulder surgery, providing effective regional anesthesia.However, breakthrough pain and the need for supplemental analgesics, often opioids, remain a challenge.

The study suggests that incorporating ketamine into existing protocols could significantly improve pain management outcomes and reduce reliance on potentially harmful opioids. Further research is warranted to determine the optimal dosage of ketamine and to identify patient populations who would benefit moast from this approach.

Pro tip – Ketamine works differently than opioids, affecting pain perception in the brain. This unique mechanism may reduce the risk of addiction and side effects.

The research team noted that while the results are promising, careful patient selection and monitoring are essential when using ketamine due to its potential side effects, including psychological effects.Though, the benefits observed in this study suggest that, when used appropriately, ketamine supplementation represents a valuable tool for enhancing post-operative pain management following shoulder surgery and contributing to a safer, more comfortable recovery for patients.

Reader question – Do you think wider adoption of ketamine supplementation could change how post-surgical pain is managed? Share your thoughts!